Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Is Amphastar (AMPH) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:47pm, Friday, 11'th Aug 2023
Amphastar (AMPH) could produce exceptional returns because of its solid growth attributes.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
12:17pm, Friday, 11'th Aug 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to AMPH, RDY and TEVA.
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
09:56pm, Tuesday, 08'th Aug 2023
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.39 per share a year ago.
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2023 Earnings Call Transcript
08:35pm, Tuesday, 08'th Aug 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Dan Dischner - Senior Vice President of Corporate Communications Bill Pet
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023
04:10pm, Wednesday, 02'nd Aug 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 2, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2023 ended June 30, 2023, a
Amphastar Pharmaceuticals (AMPH) is a Great Momentum Stock: Should You Buy?
01:10pm, Wednesday, 26'th Jul 2023
Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Must-Buy High-Flying Mid-Caps to Enhance Your Portfolio
10:37am, Wednesday, 19'th Jul 2023
We have narrowed our search to five mid-cap stocks with more than 50% returns year to date. These are: PGTI, SHAK, IDCC, ANF, AMPH.
Amphastar (AMPH) is an Incredible Growth Stock: 3 Reasons Why
02:04pm, Wednesday, 12'th Jul 2023
Amphastar (AMPH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
3 Profitable Stocks Worth Investing in Using Net Income Ratio
10:08am, Friday, 07'th Jul 2023
PDD Holdings (PDD), Amphastar Pharmaceuticals (AMPH) and Suzano (SUZ) are some of the top picks with a high net income ratio.
Amphastar Pharmaceuticals (AMPH) Is Up 0.54% in One Week: What You Should Know
01:02pm, Wednesday, 05'th Jul 2023
Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Promising Small Biotech Amphastar Sees Actionable Pullback
08:36am, Wednesday, 28'th Jun 2023
Amphastar Pharmaceuticals Inc. NASDAQ: AMPH, a small cap that's one of the leading performers within the biotech space, is forming an orderly pullback and is currently actionable as it holds above its
3 Reasons Growth Investors Will Love Amphastar (AMPH)
02:16pm, Monday, 26'th Jun 2023
Amphastar (AMPH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?
11:09am, Friday, 23'rd Jun 2023
Here is how Amphastar Pharmaceuticals (AMPH) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
4 Top-Ranked Profitable Stocks to Buy Using Net Income Ratio
07:16am, Tuesday, 20'th Jun 2023
PDD Holdings Inc. (PDD), Tecnoglass (TGLS), Amphastar Pharmaceuticals (AMPH) and Axon Enterprise (AXON) have been selected as the top picks with a high net income ratio.
Here is Why Growth Investors Should Buy Amphastar (AMPH) Now
01:53pm, Thursday, 08'th Jun 2023
Amphastar (AMPH) possesses solid growth attributes, which could help it handily outperform the market.
